Subtle Medical to expand AI imaging solutions with latest funding

Subtle Medical announced that it raised $12.2 million in Series A funding to grow its artificial intelligence (AI) product portfolio and support the demand to make medical imaging faster and safer. CEO Enhao Gong remarked that the financial support "will help us execute our vision more rapidly and with global impact."

According to Subtle Medical, the funding will be "used to pursue rapid geographic expansion to meet consumer demand, which has seen an uptick since COVID-19 began as centres require more flexibility to perform additional cleaning protocols between patients and the ability to increase capacity to accommodate the surge in postponed scan volume." The company added that the financing will also boost its product pipeline, which includes SubtleGAD for lowering gadolinium dose in contrast-enhanced magnetic resonance imaging, and technologies in image-guided therapies and pharmaceutical applications.

Subtle Medical noted that it produces the first AI-powered software solutions for vendor-agnostic medical imaging enhancement, SubtleMR and SubtlePET, which are both FDA-cleared and CE-marked.

To ensure you don't miss other Top Stories like these and news on key medtech industry developments, sign up for our free daily e-newsletter here.  

Did you like this article?